Deborah Ladenheim

Treatment-emergent adverse events after infusion of adherent stem cells: the MiSOT-I score for solid organ transplantation

M. Koller, E. Geissler, H. Schlitt, 2012, Trials.

Safety and feasibility of third-party multipotent adult progenitor cells for immunomodulation therapy after liver transplantation--a phase I study (MISOT-I)

James A. Hutchinson, M. Koller, E. Geissler, 2011, Journal of Translational Medicine.

Assessing the safety of stem cell therapeutics.

Jens Kurth, Gopalan Narayanan, Hugh Laverty, 2011, Cell stem cell.

Assessing the safety of stem cell therapeutics.

N. Benvenisty, H. Laverty, P. Andrews, 2011, Cell stem cell.